• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Helsinn Group launches Akynzeo injection in US market

    PHARMABIZ

    Helsinn`s AKYNZEO® Injection Now Available in Ready-to-Use Vial in the US

    GLOBENEWSWIRE

    Glenmark introduces medication to prevent chemotherapy-induced nausea

    ECONOMIC TIMES

    FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Fosnetupitant Chloride Hydrochloride and Palonosetron Hydrochloride

    FDA

    Taiho Pharmaceutical Submits New Drug Application for NK1 Receptor

    PRESS RELEASE

    Helsinn Group announces AKYNZEO® injection – a new liquid IV solution

    GLOBENEWSWIRE

    Helsinn announces launch of oral formulation of Akynzeo® in China

    GLOBENEWSWIRE

    Five meds recommended in final 2019 CHMP meeting

    PHARMA TIMES

    Glenmark launches Helsinn`s Akynzeo in India

    BIOSPECTRUM

    Glenmark expands its oncology franchise in India with launch of Akynzeo

    ECONOMIC TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.